Xeris Biopharma Holdings Inc (XERS) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

Data del prossimo reportMay 14, 2024

Stimato per Q2 24:$-0.12

Cambiamenti implicati per il Q1 24:+20.00%

Cambiamenti implicati per il Q2 23:-52.00%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q1 24	May 9, 2024	$-0.14 / $-0.12	$-0.02 / -16.67%
Q4 23	Mar 6, 2024	$-0.1 / $-0.09	$-0.01 / -11.11%
Q3 23	Nov 9, 2023	$-0.09 / $-0.12	$0.03 / 25%
Q2 23	Aug 8, 2023	$-0.14 / $-0.13	$-0.01 / -7.69%
Q1 23	May 9, 2023	$-0.12 / $-0.17	$0.05 / 29.41%
Q4 22	Mar 8, 2023	$-0.1 / $-0.16	$0.06 / 37.5%
Q3 22	Nov 9, 2022	$-0.14 / $-0.17	$0.03 / 17.65%
Q2 22	Aug 10, 2022	$-0.19 / $-0.23	$0.04 / 17.39%

Fornitori di Dati: Xignite Logo